Eli Lilly in pact with Magnet Bio to develop cancer drugs in a deal worth up to $1.25B
Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...
Eli Lilly to spend billions on new pharmaceutical manufacturing sites
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
BioSpace1d
Lilly Puts $27B Into U.S. Manufacturing Bump Following Trump’s Tariff Threats
The move comes after President Donald Trump warned Big Pharma leaders that he would impose tariffs on them if they refuse to ...